Articles

Nvidia will replace Intel in the Dow Jones Industrial Average, illustrating a changing of the guard in technology and the downfall of what was once an industry titan.

Wall Street was growing more bullish in the final weeks before the Nov. 5 presidential election — a contrarian sign that may suggest limited upside for U.S. stocks.

Cinemark Holdings Inc.’s better-than-expected third-quarter results this week bode well for the movie-theater chain amid a broader industry rebound, analysts said.

Big cloud companies aren’t backing down from their AI spending, which bodes well for Nvidia.

Like a squirrel trying to find an acorn in a grassy field, it’s hard to find a nugget of good news in a bad October jobs report. The unemployment rate staying at 4.1% might be the only one that qualifies.

It took less than four hours for the impact of Friday’s weak nonfarm payrolls report for October to fade, as bond-market traders shook off the surprising data and sent the benchmark 10-year yield back toward its highest levels since early July

The Internal Revenue Service said Friday that 401(k) contribution limits will climb to $23,500 next year, meaning retirement savers will be able to tuck away a little more in 2025.

Boeing’s stock rose Friday on hopes for an end to a costly strike as members of its machinists union geared up for a third contract vote on Monday, but its bonds were also looking attractive.

This election, older voters are worrying about issues that may not seem to directly affect them.

The headline figure of 12,000 jobs from the latest labor-market report is getting all the attention — but as usual, the much more interesting stuff is buried in the fine print.

A jobs report skewed by hurricanes and a strike at Boeing landed on voters’ radar with less than a week until Election Day, scrambling the picture of the U.S. economy as Kamala Harris and Donald Trump prepare to face off against each other after one of the most bitter presidential campaigns in recent memory.

Viking Therapeutics Inc.’s stock rose 2% Friday as excitement continued to build about data on its oral weight-loss drug the company will present at the upcoming Obesity Week event.